Kevin Land/LinkedIn
Apr 14, 2026, 09:09
Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
Kevin Land, Interim Laboratory and Medical Director Adult HSC Lab at UPMC Hillman Cancer Center, shared a post on LinkedIn։
“How cool is this clinical impact?
Deep normalization of hemoglobin with near‑elimination of vaso‑occlusive events in most treated patients, achieved by directly reactivating fetal hemoglobin at the γ‑globin promoters.
Compared with standard sickle cell care, often with multiple vaso-occlusive crises a year per patient, this represents a step‑change, from disease mitigation and symptomatic care to functional correction.
Early data suggests durable benefit driven by stable stem‑cell editing.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients